stockrowRedhill Biopharma Ltd. (RDHL) vs Sonoma Pharmaceuticals, Inc. (SNOA)
- Redhill Biopharma Ltd. RDHL 0.43 0.00%
- Sonoma Pharmaceuticals, Inc. SNOA 1.12 +4.67%
Redhill Biopharma Ltd. and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Sonoma Pharmaceuticals, Inc. is the larger, with a market value of $5.1M against $3.8M — 1.4× the size. Sonoma Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 47.0% against −61.9%. Redhill Biopharma Ltd. has the higher net margin (25.2% vs −10.3%) and the higher return on invested capital (0.00% vs −70.0%). Across the 16 metrics below, Redhill Biopharma Ltd. leads on 9 and Sonoma Pharmaceuticals, Inc. on 7.
Valuation
| Metric | RDHL | SNOA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 20.55 |
| P/S | 0.00 | 0.19 | 2.08 |
| P/B | n/m | 0.63 | 1.79 |
| Price to free cash flow | n/m | n/m | 16.29 |
| EV/EBITDA | n/m | 0.86 | 12.22 |
| EV/Sales | 6.43 | (0.05) | 2.87 |
| Earnings yield | (142,015.51%) | (112.96%) | (15.94%) |
| Free cash flow yield | (231,394.02%) | (63.92%) | 0.00% |
Profitability
| Metric | RDHL | SNOA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 35.16% | 38.91% | 53.51% |
| Operating margin | 0.00% | (6.41%) | 0.00% |
| Net margin | 25.20% | (10.33%) | (2.45%) |
| Free cash flow margin | 0.00% | (12.11%) | 0.00% |
| Return on equity | 0.00% | (42.52%) | (0.80%) |
| Return on assets | 0.00% | (13.85%) | (1.67%) |
| Return on invested capital | 0.00% | (69.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack